Sign Out
Click on icon to see table/diagram/imageSome adverse effects are reported with tetracycline therapy in general: Dental dyschromia and/or enamel hypoplasia may occur if the product is administered in children younger than 8 years of age.
Haemolytic anaemia, eosinophilia and other hematologic disorders have been reported with tetracycline therapy.
Extra-renal hyperazotemia linked to an anti-anabolic effect which may be intensified by the association with diuretics has been reported with tetracycline therapy.
Treatment should cease if any evidence of raised intracranial pressure develop during treatment with Tetralysal.
View ADR Reporting Link
Continue with Google